title: PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.
authors.affiliation: Departments of aGenetics bBioengineering, Stanford University, Stanford, California cDepartment of Anesthesiology dMoffitt Cancer Center, DeBartolo Family Personalized Medicine Institute, Tampa, Florida, USA eGenomics England, Queen Mary University of London, London, UK.
authors.forename: Maria L
authors.initials: ML
authors.lastname: Alvarellos
authors.forename: Ellen M
authors.initials: EM
authors.lastname: McDonagh
authors.forename: Sephalie
authors.initials: S
authors.lastname: Patel
authors.forename: Howard L
authors.initials: HL
authors.lastname: McLeod
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D001049:Apnea / Q000139:chemically induced / Q000235:genetics; D002091:Butyrylcholinesterase / Q000172:deficiency / Q000235:genetics; D015220:Calcium Channels / Q000235:genetics; D020746:Calcium Channels, L-Type; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000235:genetics; D008305:Malignant Hyperthermia / Q000209:etiology / Q000235:genetics; D008661:Metabolism, Inborn Errors / Q000139:chemically induced / Q000235:genetics; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D019837:Ryanodine Receptor Calcium Release Channel / Q000235:genetics; D013390:Succinylcholine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology
chemical_list: C412223:CACNA1S protein, human; D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D009467:Neuromuscular Depolarizing Agents; D019837:Ryanodine Receptor Calcium Release Channel; D002091:Butyrylcholinesterase; D013390:Succinylcholine